A Clinical Trial to Evaluate the Efficacy and Safety of YMC026 in Respiratory Disease Patients

PHASE4CompletedINTERVENTIONAL

Enrollment

223

Participants

Timeline

Start Date

October 27, 2017

Primary Completion Date

April 11, 2018

Study Completion Date

October 30, 2018

Conditions

Respiratory Disease

Interventions

DRUG

YMC026

YMC026 20mL TID

DRUG

Placebo

Placebo 20mL TID

Trial Locations (1)

The Catholic University of Korea, Seoul St.Mary's Hospital, Seoul

All Listed Sponsors

lead

Yuhan Corporation

INDUSTRY

NCT03334916 - A Clinical Trial to Evaluate the Efficacy and Safety of YMC026 in Respiratory Disease Patients | Biotech Hunter | Biotech Hunter